ProHealth and the HHV-6 Foundation will host a free presentation & Q&A session by XMRV researcher Judy Mikovits, PhD – to be held in Santa Barbara, CA, and streamed live on ProHealth.com Friday, January 22, 2010. Annette Whittemore, founder and president of the Whittemore-Peterson Institute, will open the event.
TIME:
2 to 4 pm Pacific Time, Friday Jan 22
For the date and time of the event where you live, check the World Clock Time Converter – www.timeanddate.com/worldclock/converter.html – and convert from U.S.A. California to your time zone.
PHYSICAL LOCATION:
Santa Barbara Central Library – 40 E Anapamu
(Downtown across from the Courthouse, corner of Anapamu & Anacapa.)
Very convenient parking adjacent to the library, easy wheelchair access.
See map – www.eventective.com/provider/map.aspx?num=112418
TO RESERVE A TICKET – If You Wish to Attend in Person
Seating is limited, so individuals or groups wishing to attend the free event in person must register to reserve seats – ASAP.
To request a ticket by e-mail, click here.
(Please provide your name and physical address – which will be kept confidential – so that we may mail you a ticket.)
TO JOIN THE EVENT AS IT IS STREAMED ONLINE
Watch ProHealth.com the week of January 18 for information on how to connect.
TO SUBMIT YOUR QUESTION TO DR. MIKOVITS
Attendees at the event in Santa Barbara will be able to question Dr. Mikovits directly about XMRV research progress, findings, testing, and plans. But Dr. Mikovits invites all to submit questions now, for her consideration in advance.
To submit a question, click here.
BRIEF BACKGROUND
Dr. Mikovits
As director of research at the Whittemore-Peterson Institute in Reno, Nevada, Judy Mikovits gained worldwide attention in October with publication of a paper in the journal Science, reporting “Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome.” To review the article and subsequent media coverage, see “In The News” at WPInstitute.org.
XMRV Research Continues, Worldwide
Dr. Mikovits’ team at Whittemore-Peterson, and collaborating researchers around the globe, are working intensively on next steps in the research – which relates to ME/CFS, fibromyalgia and other neuroimmune disorders, certain cancers, and much more.